SCHEMBL8059240

SCHEMBL8059240

Cn1c(C(=O)NC(=N)N)c2c3c(cccc31)C(OS(C)(=O)=O)CC2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8069997 0.90 KDM4E (0.32) BCHEACHE
SCHEMBL8059237 0.85 DRD2 (0.30)
SCHEMBL8059301 0.85 CA1 (0.33)
SCHEMBL8070430 0.80 PARP1 (0.36)
SCHEMBL8059334 0.76 NLRP3 (0.31)
SCHEMBL8059305 0.76 KDM4E (0.33)
SCHEMBL8070580 0.75 MEN1 (0.32)
SCHEMBL8069998 0.74 KDM4E (0.31)
SCHEMBL8068400 0.73
SCHEMBL8070377 0.73 BRD4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0803501-B1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors SUMITOMO PHARMA (JP) 2000-07-05 EP disclosed
EP-0803501-A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-10-29 EP disclosed